Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: Significance of dicysteine C30C31 motif

Annals of Neurology

Volumn 63, Issue 3, 2008, Pages 366-376

  Mishra, Mamata ^a   Vetrivel, S ^a   Siddappa, Nagadenahalli B ^b   Ranga, Udaykumar ^b   Seth, Pankaj ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTINE; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL DEATH; CELL VIABILITY; CLADISTICS; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NERVE CELL; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; STEM CELL; WESTERN BLOTTING;

AMINO ACID MOTIFS; CELLS, CULTURED; CYSTEINE; GENE PRODUCTS, TAT; HIV-1; HUMANS; NEURONS; STEM CELLS;

EID: 41849099281     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21292     Document Type: Article

References (49)

1. Clements JE, Zink MC. Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev 1996;9:100-117.
2. McArthur JC. Neurologic manifestations of AIDS. Medicine 1987;66:407-437.
3. Eugenin EA, Osiecki K, Lopez L, et al. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 2006;26:1098-1106.
4. Conant K, Garzino-Demo A, Nath A, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998;95:3117-3121.
5. Kolb SA, Sporer B, Lahrtz F, et al. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol 1999;93:172-181.
6. van Marle G, Henry S, Todoruk T, et al. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 2004;329:302-318.
7. Kelder W, McArthur JC, Nance-Sproson T, et al. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 1998;44:831-835.
8. Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev 2005;5:69-81.
9. Weis S, Haug H, Budka H. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study. Acta Neuropathol (Berl) 1993;85:185-189.
10. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 2002;186(suppl 2):S193-S198.
11. Kruman, II, Nath A, Mattson MP. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 1998;154:276-288.
12. Aksenov MY, Hasselrot U, Bansal AK, et al. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 2001;305:5-8.
13. Aksenov MY, Hasselrot U, Wu G, et al. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 2003;987:1-9.
14. Korber BT, Allen EE, Farmer AD, Myers GL. Heterogeneity of HIV-1 and HIV-2. Aids 1995;9(suppl A):S5-S18.
15. Blackard JT, Renjifo B, Fawzi W, et al. HIV-1 LTR subtype and perinatal transmission. Virology 2001;287:261-265.
16. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, et al. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 2000;74:3740-3751.
17. Roof P, Ricci M, Genin P, et al. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology 2002;296:77-83.
18. Ndung'u T, Sepako E, McLane MF, et al. HIV-1 subtype C in vitro growth and coreceptor utilization. Virology 2006;347:247-260.
19. Siddappa NB, Dash PK, Mahadevan A, et al. Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India. J Clin Microbiol 2004;42:2742-2751.
20. Esparza J, Bhamarapravati N. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? Lancet 2000;355:2061-2066.
21. McCutchan FE. Understanding the genetic diversity of HIV-11. AIDS 2000;14(suppl 3):S31-S44.
22. Shankar SK, Mahadevan A, Satishchandra P, et al. Neuropathology of HIV/AIDS with an overview of the Indian scene. Indian J Med Res 2005;121:468-488.
23. Satishchandra P, Nalini A, Gourie-Devi M, et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J Med Res 2000;111:14-23.
24. Hu DJ, Buve A, Baggs J, et al. What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS 1999;13:873-881.
25. Ranga U, Shankarappa R, Siddappa NB, et al. Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 2004;78:2586-2590.
26. Nath A, Psooy K, Martin C, et al. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996;70:1475-1480.
27. Messam CA, Hou J, Gronostajski RM, Major EO. Lineage pathway of human brain progenitor cells identified by JC virus susceptibility. Ann Neurol 2003;53:636-646.
28. Siddappa NB, Venkatramanan M, Venkatesh P, et al. Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein. Retrovirology 2006;3:53.
29. Seth P, Diaz F, Tao-Cheng JH, Major EO. JC virus induces nonapoptotic cell death of human central nervous system progenitor cell-derived astrocytes. J Virol 2004;78:4884-4891.
30. Schreck R, Baeuerle PA. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. Methods Enzymol 1994;234:151-163.
31. Singh IN, Goody RJ, Dean C, et al. Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: differential involvement of caspase-3 and endonuclease G. J Neurovirol 2004;10:141-151.
32. Bonavia R, Bajetto A, Barbero S, et al. HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem Biophys Res Commun 2001;288:301-308.
33. New DR, Ma M, Epstein LG, et al. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 1997;3:168-173.
34. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′- tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993;197:40-45.
35. Keswani SC, Polley M, Pardo CA, et al. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol 2003;54:287-296.
36. Gartlon J, Kinsner A, Bal-Price A, et al. Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicol In Vitro 2006;20:1569-1581.
37. King JE, Eugenin EA, Buckner CM, Berman JW. HIV tat and neurotoxicity. Microbes Infect 2006;8:1347-1357.
38. Tornatore C, Nath A, Amemiya K, Major EO. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 1991;65:6094-6100.
39. Asante EA, Linehan JM, Gowland I, et al. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A 2006;103:10759-10764.
40. Yin S, Pham N, Yu S, et al. Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans. Proc Natl Acad Sci U S A 2007;104:7546-7551.
41. Shojania S, O'Neil JD. HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy. J Biol Chem 2006;281:8347-8356.
42. Bayer P, Kraft M, Ejchart A, et al. Structural studies of HIV-1 Tat protein. J Mol Biol 1995;247:529-535.
43. Gregoire C, Peloponese JM Jr, Esquieu D, et al. Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein. Biopolymers 2001;62:324-335.
44. Peloponese JM Jr, Gregoire C, Opi S, et al. 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. C R Acad Sci III 2000;323:883-894.
45. Peloponese JM Jr, Collette Y, Gregoire C, et al. Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J Biol Chem 1999;274:11473-11478.
46. Pantano S, Carloni P. Comparative analysis of HIV-1 Tat variants. Proteins 2005;58:638-643.
47. Pantano S, Tyagi M, Giacca M, Carloni P. Molecular dynamics simulations on HIV-1 Tat. Eur Biophys J 2004;33:344-351.
48. Brake DA, Debouck C, Biesecker G. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat. J Cell Biol 1990;111:1275-1281.
49. Barillari G, Gendelman R, Gallo RC, Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A 1993;90:7941-7945.